Skip to content
Open access

Influenza Vaccine Effectiveness Against Mild and Severe Outcomes: A Comparison Study in Portugal

Aug 2026 · Influenza and Other Respiratory Viruses · Vol 20 · 0 citations · 29 references
Medicine

TL;DR

This study aimed to compare IVE against mild and severe influenza within primary care and hospital networks in Portugal from 2015/16 to 2023/24.

Abstract

Influenza vaccination is an effective public health intervention to lessen influenza effect on healthcare and has been recommended to prevent severe outcomes. Previous studies present higher influenza vaccine effectiveness (IVE) estimates against primary care medically attended (outpatients) compared to hospitalised cases (inpatients). Inconsistencies in study designs may hinder comparisons of IVE in preventing mild (outpatient consultations) versus severe influenza (inpatient admissions). We aimed to compare IVE against mild and severe influenza within primary care and hospital networks in Portugal from 2015/16 to 2023/24.

Read PDF

Similar papers

Open access Sep 2026

Protective effect of influenza vaccine in Brazilian patients hospitalised for severe acute respiratory infection, 2023-2025

Two doses of influenza vaccine were moderately effective in decreasing in-hospital mortality and stay among SARI-hospitalised influenza patients, and including 50-59-year-olds in a priority vaccination group may significantly reduce influenza-related adverse outcomes.

E. Kupek · 0 citations
Open access Aug 2026

Live Attenuated Influenza Vaccine (LAIV) for Children for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis

In Sweden, the implementation of LAIV is estimated to be cost-effective in 2-17-year-olds by reducing disease burden and healthcare costs in both children and the broader population.

P. Brodin, F. Wilczyński, Luca Ricci-Pacifici et al. · 0 citations
Open access Sep 2026

Influenza vaccine effectiveness in patients with chronic obstructive pulmonary disease: a cohort study emulating a randomized trial.

OBJECTIVES Many observational studies of influenza vaccine effectiveness have faced issues of residual confounding and immortal time bias. We aimed to assess the effectiveness in people with COPD, using a novel study design to address these methodological challenges. METHODS We conducted a cohort study emulating a ra...

S. Galmiche, S. Dell'Aniello, L. Lévesque et al. · 0 citations
Open access Oct 2026

Potential impact of changes in influenza vaccination coverage and effectiveness on pediatric influenza burden in the United States, 2022/23-2024/25

Background and Objectives: Influenza vaccination has a strong safety record and is effective in reducing pediatric influenza-associated morbidity and mortality. However, pediatric vaccination coverage (VC) has declined since the 2019/20 influenza season in the United States. We estimated the impact of increased vaccine...

S. E. Morris, S. Mathis, J. Chung et al. · 0 citations
Review Sep 2026

Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.

Importance Influenza continues to cause significant mortality and morbidity in the US. Seasonal influenza vaccines reduce the severity of disease and prevent hospitalizations and death, especially among individuals at high risk. Objective To identify and summarize the most recently published research spanning several...

Emily Senerth, Seyyedeh Mahsa Sheikholeslamian, Kapeena Sivakumaran et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.